More than 60 organizations, including NVHR, signed onto a letter urging the Trump administration to invest in the Department of Health & Human Services Viral Hepatitis Action Plan and to commit in words and action to the elimination of HBV and HCV in the United States by 2030. You may download a copy of the letter here.
Last Updated on May 13, 2020 by HepFree NYC
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
Fieldwork East Inc., is an independent national multi-office market research facility, specializing in medical research for new product development.
As New York State enters this era of successful HCV treatment, the NYSDOH AIDS Institute has developed criteria for defining those providers qualified to manage and treat patients with HCV infection.
The NYC Hep B Coalition is currently accepting nominations for a new Community Chair. See responsibilities and qualifications, nominate yourself or someone else!
Learn about FREE VIRAL HEPATITIS TRAINING opportunities throughout New York State.
This special event featured presentations on the Hep C Outbreak in Midwest and current Hepatitis programs in Hawaii.
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
This statement calls on all stakeholders to work together on a solution that ends the current practice of rationing hepatitis C treatment and sends a strong statement that all lives are worth saving.
